Aug 07, 2019 / 08:30PM GMT
Operator
Good afternoon and thank you for joining us today to discuss OptimizeRx's second quarter ended June 30, 2019. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by the company's Chief Commercial Officer, Stephen Silvestro; as well as the Company's President, Miriam Paramore; and its Chief Financial Officer, Doug Baker.
Following their remarks, we'll open the call to questions. Then before we conclude today's call, I'll provide some important cautions regarding the forward-looking statements made by the management during the call.
I'd like to remind everyone that today's call is being recorded and will be made available for telephone replay via instructions in today's press release in the Investors section of the Company's website.
Now I'd like to turn the call over to OptimizeRx's CEO, William Febbo. Please go ahead, sir.
William J. Febbo - OptimizeRx Corporation - CEO & Director
Thank you, Nadia, and good afternoon, everyone. Thanks for joining us on the call today.
In Q2, we
Q2 2019 OPTIMIZERx Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot